Evidence map›Paper›PMID 20464428›Full record

ArticlePediatric nephrology (Berlin, Germany)2010

Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS.

Meredith A Atkinson, Karen Martz, Bradley A Warady, Alicia M Neu

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Anemia and Associated Risk Factors in Pediatric Patients.Pediatric health, medicine and therapeutics · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Measurement of iron status in chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2019
    Review
  18. Review
  19. Article
  20. Anemia in chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Meredith A AtkinsonDivision of Pediatric Nephrology, Johns Hopkins University, 200 N Wolfe St, Baltimore, MD 21287, USA. matkins3@jhmi.edu
Karen Martz
Bradley A Warady
Alicia M Neu
Johns Hopkins University · USChildren's Mercy Hospital · USEmmes (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies in children with chronic kidney disease (CKD) have identified low hemoglobin as a risk factor for poor outcomes. A retrospective review of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) CKD registry was performed to identify the prevalence of and risk factors for anemia among children with stage 3 CKD, including both patients with low hemoglobin and those whose hemoglobin normalized with an erythropoiesis-stimulating agent (ESA). At enrollment, 2,792 patients had stage 3 CKD. Mean age was 9.5 (+/-0.11) years, 62.1% were male, 61.3% were white, and 43.7% had structural/urologic disease. Among 1,640 of those patients with 12 month follow-up data available for multivariate analysis, 73% met the criteria for anemia. Multivariate logistic regression analysis identifying risk factors for anemia at the 12-month follow-up revealed that, after controlling for estimated glomerular filtration rate, age >2 years, male sex, earlier era of study entry, and prescription of anti-hypertensive medications are associated with an increased risk for anemia at 12 months. In addition, multivariate Cox proportional hazards regression analysis revealed that when patients with ESA-corrected hemoglobin are included in the definition, anemia is not associated with increased risk of progression to end stage renal disease (dialysis initiation or transplantation).

Indexed as

AdolescentAnemiaChildChild, PreschoolChi-Square DistributionChronic DiseaseClinical Trials as TopicFemaleHematinicsHumansInfantInfant, NewbornKidney DiseasesLogistic ModelsMaleNorth AmericaHematinics

Identifiers

PMID20464428
OpenAlexW2017277529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.